University of California San Francisco Cardiac Amyloidosis Program | oneAMYLOIDOSISvoice
×
Or register here
Global Search

Trusted Resources: People & Places

Healthcare providers, researchers, and advocates

Back to Places / Academic & Health Care Centers
University Of California San Francisco Cardiac Amyloidosis Program

University of California San Francisco Cardiac Amyloidosis Program

535 Mission Bay Blvd. South
San Francisco, California, United States
Phone   Web  

The University of California San Francisco (UCSF) Amyloid Heart Disease Program provides comprehensive, patient-centered care for all forms of cardiac amyloidosis. They are committed to offering access to state-of-the-art approaches for both diagnosis and treatment. To accomplish this, they routinely participate in clinical trials and expanded access programs for the most promising therapies. Patients are followed closely by nurses and pharmacists in the UCSF Heart Failure Clinic to help manage symptoms of heart failure and maintain the best quality of life possible.

Effective treatment of amyloidosis requires a multidisciplinary team. As part of the UCSF Amyloid Center, they work closely with other amyloid specialists from hematology-oncology, neurology, liver transplant, nephrology, radiology, pathology, and more to offer patients the integrated treatment they need. The center serves as a resource for the support of patients, family members and caregivers. 

The team includes healthcare professionals in the following areas:

Hematology and Oncology:
Sandy W. Wong, MD

Cardiology:
Van Selby, MD; Teresa De Marco, MD

Nephrology:
Kerry Cho, MD, FACP

Related Content

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close

Community Key Collaborator

Support for this landing page is provided by an independent education grant from

Translation of this platform made possible through an independent education grant from

© 2025 rareLife solutions Inc.

To improve your experience on this site, we use cookies. This includes cookies essential for the basic functioning of our website, cookies for analytics purposes, and cookies enabling us to personalize site content. By clicking on 'Accept' or any content on this site, you agree that cookies can be placed. You may adjust your browser's cookie settings to suit your preferences.
More information

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close